• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰老与纤溶酶原激活物抑制剂-1(PAI-1)调节:对老年人血栓形成性疾病发病机制的影响

Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

作者信息

Yamamoto Koji, Takeshita Kyosuke, Kojima Tetsuhito, Takamatsu Junki, Saito Hidehiko

机构信息

Department of Transfusion Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya 466-8550, Japan.

出版信息

Cardiovasc Res. 2005 May 1;66(2):276-85. doi: 10.1016/j.cardiores.2004.11.013. Epub 2004 Dec 8.

DOI:10.1016/j.cardiores.2004.11.013
PMID:15820196
Abstract

Thrombotic cardiovascular diseases increase in incidence in the elderly, a tendency dependent on the age-related changes in vascular and hemostatic systems that include platelets, coagulation, and fibrinolytic factors as well as in the endothelium. The hypercoagulability of and advanced sclerotic changes in the vascular wall may contribute to the increased incidence of thrombosis in the elderly. One of the important key genes for aging-associated thrombosis is plasminogen activator inhibitor-1 (PAI-1), a principal inhibitor of fibrinolysis. The expression of PAI-1 is not only elevated in the elderly but also significantly induced in a variety of pathologies associated with the process of aging. These conditions include obesity, insulin resistance, emotional stress, immune responses, and vascular sclerosis/remodeling. Several cytokines and hormones, including tumor necrosis factor-alpha, transforming growth factor-beta, angiotensin II, and insulin, positively regulate the gene expression of PAI-1. The recent epidemic in obesity with aging in the industrialized society may heighten the risk for thrombotic cardiovascular disease because adipose tissue is a primary source of PAI-1 and cytokines. Emotional or psychosocial stress and inflammation also cause the elevated expression of PAI-1 in an age-specific pattern. Thus, PAI-1 could play a key role in the progression of cardiovascular aging by promoting thrombosis and vascular (athero)sclerosis. Further studies on the genetic mechanism of aging-associated PAI-1 induction will be necessary to define the basis for cardiovascular aging in relation to thrombosis.

摘要

血栓性心血管疾病的发病率在老年人中呈上升趋势,这种趋势取决于血管和止血系统中与年龄相关的变化,这些系统包括血小板、凝血因子、纤维蛋白溶解因子以及内皮细胞。血管壁的高凝性和晚期硬化改变可能导致老年人血栓形成的发病率增加。与衰老相关血栓形成的重要关键基因之一是纤溶酶原激活物抑制剂-1(PAI-1),它是纤维蛋白溶解的主要抑制剂。PAI-1的表达不仅在老年人中升高,而且在与衰老过程相关的各种病理状态下也会显著诱导。这些情况包括肥胖、胰岛素抵抗、情绪应激、免疫反应以及血管硬化/重塑。几种细胞因子和激素,包括肿瘤坏死因子-α、转化生长因子-β、血管紧张素II和胰岛素,正向调节PAI-1的基因表达。在工业化社会中,随着年龄增长肥胖症的流行可能会增加血栓性心血管疾病的风险,因为脂肪组织是PAI-1和细胞因子的主要来源。情绪或心理社会应激以及炎症也会以年龄特异性模式导致PAI-1表达升高。因此,PAI-1可能通过促进血栓形成和血管(动脉粥样)硬化在心血管衰老进程中发挥关键作用。有必要对衰老相关的PAI-1诱导的遗传机制进行进一步研究,以确定与血栓形成相关的心血管衰老的基础。

相似文献

1
Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.衰老与纤溶酶原激活物抑制剂-1(PAI-1)调节:对老年人血栓形成性疾病发病机制的影响
Cardiovasc Res. 2005 May 1;66(2):276-85. doi: 10.1016/j.cardiores.2004.11.013. Epub 2004 Dec 8.
2
Aging and thrombosis.衰老与血栓形成。
Semin Thromb Hemost. 2002 Dec;28(6):555-68. doi: 10.1055/s-2002-36700.
3
Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.低纤溶活性和纤溶酶原激活物抑制物-1(PAI-1)增加通过胰岛素抵抗和肥胖与动脉粥样硬化血栓形成相关联。
Ann Med. 2000 Dec;32 Suppl 1:78-84.
4
Plasminogen activator inhibitor-1 in aging.纤溶酶原激活物抑制剂-1 与衰老。
Semin Thromb Hemost. 2014 Sep;40(6):652-9. doi: 10.1055/s-0034-1384635. Epub 2014 Aug 14.
5
Fat cell function and fibrinolysis.脂肪细胞功能与纤维蛋白溶解
Horm Metab Res. 2000 Nov-Dec;32(11-12):504-8. doi: 10.1055/s-2007-978677.
6
Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.纤溶酶原激活物抑制剂-1、脂肪组织与胰岛素抵抗
Curr Opin Lipidol. 2007 Jun;18(3):240-5. doi: 10.1097/MOL.0b013e32814e6d29.
7
Visceral fat as a determinant of fibrinolysis and hemostasis.内脏脂肪作为纤维蛋白溶解和止血的一个决定因素。
Semin Vasc Med. 2005 Feb;5(1):48-55. doi: 10.1055/s-2005-871741.
8
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.肥胖与纤维蛋白溶解功能受损:脂肪组织产生纤溶酶原激活物抑制剂-1的作用
Int J Obes Relat Metab Disord. 2004 Nov;28(11):1357-64. doi: 10.1038/sj.ijo.0802778.
9
Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review).纤溶酶原激活物抑制剂的抑制剂能否减轻肥胖和糖尿病的负担?(综述)
Int J Mol Med. 2012 Jan;29(1):3-11. doi: 10.3892/ijmm.2011.810. Epub 2011 Oct 11.
10
Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.胰岛素抵抗综合征中的纤溶功能减退:对心血管疾病的影响。
J Intern Med. 2004 Apr;255(4):448-56. doi: 10.1046/j.1365-2796.2003.01288.x.

引用本文的文献

1
Mechanisms of endothelial senescence and vascular aging.内皮细胞衰老与血管老化的机制。
Biogerontology. 2025 Jun 25;26(4):128. doi: 10.1007/s10522-025-10279-y.
2
Lyophilized MSC-EVs attenuates COVID-19 pathogenesis by regulating the JAK/STAT pathway.冻干的间充质干细胞外泌体通过调节JAK/STAT信号通路减轻COVID-19的发病机制。
Stem Cell Res Ther. 2025 May 15;16(1):244. doi: 10.1186/s13287-025-04284-8.
3
CircMYO9A inhibits influenza A virus replication by dampening haemagglutinin cleavage via increasing SERPINE1/PAI-1 expression.
环状肌球蛋白9A(CircMYO9A)通过增加丝氨酸蛋白酶抑制剂E1/纤溶酶原激活物抑制剂-1(SERPINE1/PAI-1)的表达来抑制血凝素裂解,从而抑制甲型流感病毒复制。
Emerg Microbes Infect. 2025 Dec;14(1):2502007. doi: 10.1080/22221751.2025.2502007. Epub 2025 May 20.
4
Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway.营养保健品COMP-4通过eNOS/iNOS-NO-cGMP途径对内皮功能障碍起到保护作用。
PLoS One. 2025 Feb 6;20(2):e0316798. doi: 10.1371/journal.pone.0316798. eCollection 2025.
5
Endothelial Dysfunction and Hemostatic System Activation in Relation to Shift Workers, Social Jetlag, and Chronotype in Female Nurses.女性护士的内皮功能障碍和止血系统激活与轮班工作、社会时差和生物钟类型的关系
Int J Mol Sci. 2025 Jan 8;26(2):482. doi: 10.3390/ijms26020482.
6
Insulin Resistance, Hyperinsulinemia and Atherosclerosis: Insights into Pathophysiological Aspects and Future Therapeutic Prospects.胰岛素抵抗、高胰岛素血症与动脉粥样硬化:对病理生理方面及未来治疗前景的见解
Curr Cardiol Rev. 2025;21(1):e1573403X314035. doi: 10.2174/011573403X314035241006185109.
7
Impact of Plasminogen Activator Inhibitor-1 Serum Levels and the -675 4G/5G Variant in the SERPINE1 Gene on Systemic Sclerosis in a Mexican Population.纤溶酶原激活物抑制剂-1血清水平及SERPINE1基因-675 4G/5G变异对墨西哥人群系统性硬化症的影响
Life (Basel). 2024 Aug 23;14(9):1056. doi: 10.3390/life14091056.
8
Molecular and Functional Alterations in the Cerebral Microvasculature in an Optimized Mouse Model of Sepsis-Associated Cognitive Dysfunction.在优化的脓毒症相关认知功能障碍小鼠模型中,脑微血管的分子和功能改变。
eNeuro. 2024 Sep 27;11(9). doi: 10.1523/ENEURO.0426-23.2024. Print 2024 Sep.
9
Unconventional localization of PAI-1 in PML bodies: A possible link with cellular growth of endothelial cells.纤溶酶原激活物抑制剂-1(PAI-1)在早幼粒细胞白血病(PML)小体中的非常规定位:与内皮细胞生长的潜在联系。
Biochem Biophys Rep. 2024 Jul 26;39:101793. doi: 10.1016/j.bbrep.2024.101793. eCollection 2024 Sep.
10
The mechanistic basis linking cytokine storm to thrombosis in COVID-19.将细胞因子风暴与COVID-19中的血栓形成联系起来的机制基础。
Thromb Update. 2022 Aug;8:100110. doi: 10.1016/j.tru.2022.100110. Epub 2022 May 18.